The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

0 Hinnangud
0
Osa
434 of 586
Kestus
26 min
Keel
inglise
Vorming
Kategooria
Majandus ja ettevõtlus

Goldman Sachs Research’s Chris Shibutani and Jason English explain the business and investor implications of the latest anti-obesity medications and their ripple effects in the healthcare industry and beyond. Learn more about your ad choices. Visit megaphone.fm/adchoices


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Proovi tasuta
Device Banner Block-copy 894x1036
Cover for The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior

Muud podcastid, mis võivad sulle meeldida ...